Who Should NOT Use LuciTala (Contraindications)
Absolute Contraindications
LuciTala should not be used in the following situations:
➔Hypersensitivity or Allergy:
Individuals with a known allergy to LuciTala or any of its ingredients should avoid this medicine.
➔Breastfeeding Mothers:
Use is not recommended during breastfeeding due to the potential risk of serious harm to the infant.
Important Note:
Although official prescribing information may list “no formal contraindications” clinical guidance and product labelling clearly advise avoiding use in patients with hypersensitivity and during breastfeeding.
Special Populations & Precautions
Use with caution or under close medical supervision in the following groups:
Children and Adolescents (<18 years)
-Safety and effectiveness have not been established, therefore it is not recommended for general use.
Pregnant Women
-LuciTala may cause serious harm to the unborn baby, including pregnancy loss.
-Effective contraception is required during treatment and for a period after stopping therapy.
Men Planning to Father a Child
➔Treatment may affect male fertility.
➔Reliable contraception is advised during treatment and for several months afterward.
Patients with Organ Dysfunction
Moderate to severe kidney or liver impairment may require dose adjustment or enhanced monitoring.
Severe impairment warrants extra caution.
Blood and Bone Marrow Disorders
Patients with low blood cell counts (such as anemia, neutropenia, or thrombocytopenia) or unresolved side effects from previous cancer therapy may need to delay treatment.
Important Warnings (Serious but Not Absolute Contraindications)
Serious Bone Marrow Disorders:
Rare but severe conditions such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) have been reported and may be life-threatening.
Regular blood tests are essential.
Myelosuppression:
Suppression of bone marrow function may lead to increased infection risk, bleeding, or severe anemia, requiring close medical monitoring.
Myth and Facts
Myth1: LuciTala is chemotherapy
Fact LuciTala is not traditional chemotherapy. It is a targeted therapy called a PARP inhibitor, which works by blocking a DNA-repair enzyme in cancer cells, making it harder for them to survive.
Myth 2: LuciTala works for all cancers
Fact: LuciTala only approved for specific cancers, mainly certain types of breast cancer with BRCA gene mutations. It is not effective or appropriate for every cancer type.
Myth 3:Only people with a family history of cancer can benefit
Fact: While BRCA mutations can be inherited, not everyone with a BRCA mutation has a family history. Some people discover they have the mutation only after genetic testing.
Myth 4: LuciTala cures cancer
Fact: LuciTala does not cure cancer. It is used to slow cancer growth, shrink tumors, or help control the disease, often as part of a long-term treatment plan.
Myth 5:LuciTala has no side effects because it’s targeted
Fact: Even targeted therapies can have side effects. Common ones may include: Fatigue Low blood counts Nausea Headaches Doctors monitor patients closely to manage these effects. Myth 6: Anyone can take LuciTala if they want
Fact: LuciTala is a prescription medication and is only used when a doctor determines it is safe and appropriate based on: Genetic testing results Cancer type and stage Overall health Myth7:Genetic testing isn’t necessary before using LuciTala
Fact: Genetic testing is essential. LuciTala works best in cancers with BRCA1 or BRCA2 mutations, so testing helps decide whether it’s likely to help.
Myth 8:LuciTala replaces all other cancer treatments
Fact: LuciTala may be used alone or alongside other treatments, but it does not automatically replace surgery, radiation, or other medicines.
Myth 9: Higher dose works better
Fact: Higher doses increase side effects, not effectiveness.The dose must be carefully prescribed by an oncologist.
10: It can be taken without medical supervision
Fact: LuciTala must always be taken under specialist care, with regular blood tests.
